MARKETS / NASDAQ / SLSN
NASDAQ · PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS · SMALL CAP

Solesence, Inc. SLSN

16 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$62.1M
▲ 18.6% vs FY2024
EPS · FY25
$0.02
Dividend / sh · FY25
Payout · FY25
ROE · FY25
11.0%
Net margin · FY25
2.9%
Dividend coverage
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 62.1M
Revenue, FY2025 · full 16-year series below
Revenue Net income
0.020.040.060.080.10.0201020132016201920222025
0.020.040.060.080.10.02016201920222025

3 cents of every revenue dollar became profit this year.

Per share
USD 0.02
Diluted EPS, FY2025
EPS
0.40.81.20.02201020132016201920222025
0.40.81.20.022016201920222025

The company pays no cash dividend.

Profitability
11.0%
Return on equity, FY2025
ROE
20406011.0%201020132016201920222025
20406011.0%2016201920222025
Operating margin2.5%
Net margin2.9%
Return on assets3.6%

Each USD of equity produced 11 cents of profit this year.

Returned to shareholders
returned in FY2025 · dividends + net buybacks
Dividends paid
Net buybacks
Share of profit
Consecutive raises

Growth
+29.4% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+18.5%
+29.4%
+19.7%
+13.4%
Net income
+12.6%
EPS, diluted
−7.8%

Compound annual rates per period — left blank where the series crosses a loss.

Share base
0.07B
Shares outstanding, FY2025
0.020.07201020132016201920222025
0.030.072016201920222025
Change, 5 years+84.8%
Change, 10 years+147.0%

The share count grew 85% in five years — the same company, cut into more, smaller slices.

Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 50.1M
total assets, end of FY2025
Total assetsUSD 50.1M
EquityUSD 17.6M
CashUSD 1.3M
Current ratio2.07×

Equity funds 35% of total assets.

History
16 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
Revenue $B
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Operating income $B
0.0
0.0
−0.0
−0.0
0.0
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EBITDA $B
0.0
0.0
−0.0
−0.0
0.0
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
Income tax $B
0.0
0.0
0.0
−0.0
0.0
·
·
0.0
0.0
·
0.0
0.0
0.0
·
·
·
Net income $B
0.0
0.0
−0.0
−0.0
0.0
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EPS, diluted $
0.02
0.07
−0.09
−0.05
0.05
0.03
−0.08
−0.06
−0.03
−0.04
−0.04
−0.06
−0.09
−0.10
−0.16
−0.19
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
11.0
50.3
−116.3
−40.0
45.5
46.6
−207.7
−90.2
−26.2
−45.4
−35.5
−37.5
−38.2
−31.8
−37.5
−39.0
Shares out B
0.07
0.07
0.05
0.05
0.05
0.04
0.04
0.03
0.03
0.03
0.03
0.03
0.03
0.03
0.02
0.02

Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.

How we verifyAUDITED
63 of 63
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity

Every figure was compared against the original statement: 0 failures and 0 presentation gaps.

What we don’t show

We’d rather say what’s missing than fill the gap with an estimate.

P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed